Evolving concepts in AD: Under a new research framework proposed by the National Institute on Aging and Alzheimer’s Association, it was proposed that AD should be redefined by biological markers of disease, which include neurodegeneration and markers of deposition of two pathological proteins in the brain: amyloid beta and tau [166]. This evidence concerns the gene MAPT and Alzheimer disease.